Going forward, the Journal of Orthopedics for Physician Assistants (JOPA) will be housed within the family of The Journal of Bone and Joint Surgery (JBJS) family of publications and products.
Journal of Orthopedics for Physician Assistants Joins JBJS Family
1 min read Premium comments
Secondary
“We at JBJS have long recognized the expertise and support PAs provide to today’s multi-professional medical team, ” said Paul Sandford, CEO of The Journal of Bone and Joint Surgery (JBJS Inc.), in the February 20, 2016 news release. “This acquisition will enable us to build the largest community of PAs in the orthopaedic domain, specifically targeting the needs of PA readers, researchers, and authors.”
Dagan Cloutier, PA-C, Founder and Editor of JOPA, will remain in JOPA‘s editorial leadership role. “As the publisher of The Journal of Bone & Joint Surgery—the gold-standard source of information in orthopaedics—JBJS, Inc. is well-positioned to maximize the quality and dissemination of JOPA content, ” said Cloutier.
According to the news release, “To introduce the entire orthopaedic community to the publishing of JOPA under the aegis of JBJS, Inc., JBJS will offer access to JOPA at no cost to all PAs, nurse practitioners, and other orthopaedic providers who register at the JBJS booth (#1831) during the upcoming AAOS Annual Meeting, March 1 – 5 in Orlando.”
Paul Sandford told OTW, “JBJS intends to integrate JOPA into its preexisting family of journals, including JB&JS, JBJS Case Connector, JBJS Essential Surgical Techniques, and JBJS Reviews. Dagan Cloutier will be the Editor of JOPA, serving under the leadership of JB&JS Editor-in-Chief Dr. Marc Swiontkowski. The editorial board of JOPA will consist entirely of physician assistants, leveraging the rigorous peer-review standards and editorial and copyediting processes used at JBJS. JBJS will seek to integrate all of its content that is relevant for PAs working in musculoskeletal care into packages that become central components of the ongoing educational and vital CME requirements for this audience. JOPA will leverage the prestigious JBJS brand prospectively.”
React:
Discussion
This is a fascinating development. In my practice we've seen similar outcomes with the revised protocol. The key differentiator seems to be patient selection criteria. Has anyone else noticed the correlation with BMI thresholds?
Great point. I'd push back slightly on the conclusion, the sample size in the cited study is too small to draw population-level inferences. That said, the directional signal is compelling and worth a larger RCT.
We implemented a similar approach last year. Early results are promising but we're still gathering 12-month follow-up data. Happy to share our protocol if anyone is interested.
Join the conversation
Orthopedic professionals are discussing this. Sign in and upgrade to read every comment and add your voice.